Trump, Tylenol and autism
Digest more
Tylenol, Trump and Dr. Oz
Digest more
3don MSN
Tylenol maker Kenvue plunges on reports that the White House planned to link the drug to autism
The White House is reportedly planning to link Tylenol use during pregnancy to autism. The news pushed Kenvue stock down 8%.
3don MSN
Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link
Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn’t offer fresh evidence that could be used by plaintiffs to sue the maker of Tylenol for its alleged link to autism.
Kenvue's profitability, with gross margins above 58% and EBITDA margins over 23%, provides resilience against legal and headline risks. Learn more about KVUE stock here.
Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.
Shares of consumer healthcare firm Kevnue dropped to a record low during regular trading Monday, then made up some ground afterhours as President Trump warned that acetaminophen, the active ingredient in Kenvue's Tylenol,
Fox rises after President Donald Trump said Lachlan and Rupert Murdoch could be part of an investor group to own TikTok.